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Background: Osteoporosis is the most common metabolic bone disease with complicated, multifactorial and
heterogenic nature that has no known pathological cause. As the role of Diabetes Mellitus (DM) and thyroid
dysfunctions in the prevalence of osteoporosis is not exactly known, therefore this study was designed to evaluate
the probable association between osteoporosis with DM and thyroid dysfunctions in Iranian patients.
Methods: In this cross-sectional study, 300 subjects out of the total number of patients referring to Gorgan bone
densitometry centers (3000subjects) were selected via random sampling method in 2009. Individual characteristics,
DM, thyroid dysfunctions and densitometry results were collected from densitometry records. Data analysis was
carried out by SPSS version 16 software and by using Chi square and T-test. The level of significance in all tests
was considered 0.05.
Results: The mean of T-score in lumbar and femoral areas of diabetic patients were -0.87 ± 1.08 and -1.94 ± 1.33
and in patient with thyroid dysfunctions was -0.80 ± 1.09 and -1.64 ± 1.24 respectively. The mean of BMD in lumbar
and femoral areas of diabetic patients were 0.96 ± 0.19 and 0.75 ± 0.19 and in patient with thyroid dysfunctions
were 0.96 ± 0.17 and 0.76 ±0.19 respectively. The mean of BMI in osteoporotic subjects in the lumbar and femoral
areas were 25.94 ± 5.62 and 26.95 ± 5.20 respectively. The association between BMI and BMD in the lumbar and
femoral areas were statistically significant, but the association between DM and thyroid dysfunctions with BMD and
T-score in the femoral and lumbar areas was not statistically significant (P-value > 0.05).
Conclusion: The results of current study show that there is no association between DM and thyroid dysfunctions
with osteoporosis.
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Osteoporosis is the most common metabolic bone dis-
order that is characterized by reduction of bone mass
without alteration in the composition of bone, leading to
fractures. The most obvious subclinical symptom of this
disorder is the fracture in the vertebral and femoral neck
bone [1]. Osteoporosis cause approximately 2 million frac-
tures annually, which decrease quality of life, increased
disability and even death [2]. The National Osteoporosis
Foundation estimated that approximately 45 million per-
sons over the age of 50, in 2002, in the United States were* Correspondence: mansourian55@yahoo.com
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reproduction in any medium, provided the orat risk for fracture due to osteoporosis and they estimated
that in 2020, that number is over 60 million [3]. The
osteoporosis has a complex and heterogenic nature the
cause of which is not yet known. The known risk factors
for osteoporosis are menopause, age, family history of
fracture, race, immobility, smoking, corticosteroids, and
deficiency of some nutrients such as calcium and vita-
min D [4,5]. The effect of some extrinsic causes of
osteoporosis, including genetic disorders, autoimmune
diseases (e.g. lupus, rheumatoid arthritis and etc.) endo-
crine disorders (e.g. Diabetes Mellitus (DM), Cushing’s
syndrome, hypothyroidism and hyperparathyroidism)
gastrointestinal disorders (e.g. celiac disease, gastric by-
pass, GI surgery, inflammatory bowel disease, pancre-
atic disease and cirrhosis), and hematologic disordersl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The association between BMI categories and BMD status in study population in lumbar and femoral areas
BMI categories1 P-vale
Area Status Underweight Normal Overweight Obesity
Lumbar Normal 2 (0.7) 20 (6.7) 5 (16.7) 57 (19) 0.01
Osteopenia 5 (1.7) 35 (11.7) 47 (15.7) 34 (11.3)
Osteoporosis 5 (1.7) 18 (6) 15 (5) 12 (4)
Femoral Normal 1 (0.3) 12 (4) 34 (11.3) 37 (11.3) 0.01
Osteopenia 6 (2) 25 (8.3) 44 (14.7) 40 (13.3)
Osteoporosis 5 (1.7) 36 (12) 34 (11.3) 26 (8.7)
1BMI categories: underweight: BMI < 18.5 kg/m2, normal weight: BMI; 18.5-25 kg/m2, overweight: BMI; 25-30 kg/m2, obese: BMI > 30 kg/m2.
Data are presented as number (%).
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not well known [6].
DM is accompanied by a comprehensive list of chronic
complications that affect almost all tissues. Musculoskel-
etal complications in DM have been identified since the
beginning of the 20th century [7]. As DM and osteopor-
osis are prevalent and have especial socio-economic im-
portance in society, the evaluation of the interaction of
these two diseases has been recognized even more. The
important question is that whether DM is a risk factor
for osteopenia and osteoporosis, or these disorders are
complication of DM. However, the results of bone mineral
density (BMD) in type II DM are different and sometimes
contrary [8-11]. In some studies no difference has been
observed in BMD between patients with type II DM and
healthy individuals. A number of studies have reported
lower BMD in type II diabetic patients than normal popu-
lation, while there are still others in which the BMD
has been higher in diabetics in comparison with normal
population [6].
The most common causes of secondary osteoporosis can
be mentioned as follows: increase endogenic and exogen-
ous glucocorticoids, hyperthyroidism, hyperparathyroidism,
and vitamin D deficiency [12-19]. Hyperthyroidism causes
bone erosion which has been reported to be an important
reason for the increase in the brittleness of collagenase
tissue, as well as the decrease in BMD. The role of thyroid
hormones in bone metabolism is not identified, but the
impact of T3 on osteoclasts has been suggested in bone
erosion [20]. As the role of DM and thyroid dysfunctions
in the prevalence of osteoporosis is not exactly known,Table 2 Mean of T-score and BMD in participants according to
Area Status Diabetes
Yes No
Lumbar T-score -0.87 (1.08) -1.10 (1.21)
BMD 0.96 (0.19) 0.92 (0.20)
Femoral T-score -1.94 (1.33) -1.72 (1.32)
BMD 0.75 (0.19) 0.78 (0.16)
Data are presented as mean (SD).therefore this study was designed to evaluate the prob-
able association between osteoporosis with DM and
thyroid dysfunctions among subjects referring to
Gorgan bone densitometry centers, north-east of Iran.Methods
Among 3000 subjects referring to Gorgan densitometry
centers (two centers) in 2009, 300 subjects were selected
via random sampling method. The study was approved
by ethic committee of Golestan University of Medical
Sciences. BMD of the lumbar spine (L2 and L4) and
proximal femur (femoral neck) was measured by Dual
Energy X-Ray Absorptiometry (DXA) (Norland XR-46).
According to the WHO criteria by using T-Score of
lumbar and femoral BMD, osteoporosis (T-score less
than -2.5 of standard deviation in DXA densitometry)
and osteopenia (T-Score between -1 to -2.5 of standard
deviation in densitometry) were defined [21]. The demo-
graphic data including age, weight, height, and medical
history such as endocrine disorders (DM and thyroid
dysfunctions) was collected via interview with specialist.
Weight was recorded in light clothing to the nearest 0.1
kg on a SECA digital weighing scale (SECA, Germany)
and height was measured without shoes to the nearest 0.1
cm. Body mass index (BMI) was calculated from weight
and height [BMI = weight (kg) ⁄height (m2)]. Four categor-
ies were defined for BMI: underweight (BMI < 18.5 kg/m2),
normal weight (BMI = 18.5-25 kg/m2), overweight (BMI =
25-30 kg/m2), and obese (BMI > 30 kg/m2). In the analysis
BMI was considered as a continuous and categoricalDM and thyroid dysfunctions in lumbar and femoral areas
P-
value
Thyroid dysfunctions P-value
Yes No
0.27 -0.80 (1.09) -1.09 (1.20) 0.24
0.26 0.96 (0.17) 0.92 (0.20) 0.29
0.33 -1.64 (1.24) -1.75 (1.31) 0.68
0.38 0.76 (0.19) 0.78 (0.16) 0.60
Table 3 The association of DM, thyroid dysfunctions and BMD status in study participants in lumbar and femoral areas
Area Status Diabetes P-
value
Thyroid dysfunctions P-value
Yes No Yes No
Lumbar Normal 16 (5.3) 113 (37.7) 0.53 13 (4.3) 116 (38.7) 0.80
Osteopenia 17 (5.7) 104 (34.7) 11 (3.7) 110 (36.7)
Osteoporosis 5 (1.7) 45 (15) 4 (1.3) 46 (15.3)
Femoral Normal 5 (1.7) 79 (26.3) 0.65 8 (2.7) 76 (25.3) 0.67
Osteopenia 19 (6.3) 96 (32) 12 (4) 103 (34.3)
Osteoporosis 14 (4.7) 78 (29) 8 (2.6) 93 (31)
Data are presented as number (%).
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as binary variables and BMD were regarded as continu-
ous and categorical variable (normal, Osteopenia, and
osteoporosis).
Data were analyzed using independent T-test, ANOVA
and Tukey Post hoc test, Chi square test and univariate
and multiple linear regression. Analysis was done with
SPSS version 16 software. A P-value less than 0.05 were
considered as statistically significant.
Results
Among 300 participants studied, 260 cases (86.6%) were
women, 38 cases (12.7%) were diabetic, and 28 cases
(9.3%) suffered from thyroid dysfunctions. The mean age
and BMI of the participants was 52.7 ± 14.42 years and
28.14 ± 5.42 kg/m2 respectively. The mean BMD in the
lumbar and femoral areas was 0.92 ± 0.19 g/cm² and
0.77 ± 0.16 g/cm² respectively. The mean BMI in osteo-
porotic, osteopenic, and normal subjects in the lumbar area
was 25.94 ± 5.62 kg/m2, 27.71 ± 4.93 kg/m2 and 29.38 ±
5.49 kg/m2 respectively which was statistically significant
(P-value < 0.01). Post hoc test showed that this difference
was statistically significant only between normal and osteo-
porotic cases (P- value <0.01). The association between
BMI categories and BMD in lumbar and femoral areas was
statistically significant (P-value: 0.01) (Table 1).
Mean of T-score and BMD in participants according to
DM and thyroid dysfunctions is presented in Table 2.
Mean of T-score in lumbar and femoral areas of diabeticTable 4 The association of BMI, DM, and thyroid dysfunctions w
B1 unadjusted
Lumbar area BMI (kg/m²) 0.013
Thyroid dysfunctions (Y/N) 0.014
DM (Y/N) .038
Femoral area BMI (kg/m²) 0.004
Thyroid dysfunctions (Y/N) -0.028
DM (Y/N) -0.025
1Regression coefficient.
2Adjusted for age, sex.patients was -0.87 and -1.94 and in patient with thyroid
dysfunctions was -0.80 and -1.64 respectively. Mean of
BMD in lumbar and femoral areas of diabetic patients was
0.96 and 0.75 and in patient with thyroid dysfunctions was
0.96 and 0.76 respectively. The association between DM
and thyroid dysfunctions with BMD and T-score in the
femoral and lumbar areas was not statistically significant
(P-value > 0.05).
Among 38 diabetic subjects, 17 subjects (5.7%) were
osteopenic, and 5 subjects (1.7%) were osteoporotic in
the lumbar area. In the femoral area, 19 subjects (6.3%)
were osteopenic and 14 subjects (4.7%) were osteopor-
otic which was not statistically significant in both areas
(P > 0.05) (Table 3).
The association between thyroid dysfunctions and BMD
in the femoral and lumbar areas is presented in Table 3.
Among 28 patients with thyroid dysfunctions, in their
lumbar area 11 subjects (3.7%) were osteopenic and 4 sub-
jects (1.3%) were osteoporotic and in the femoral area, 12
subjects (4%) were osteopenic and 8 subjects (2.6%) were
osteoporotic which was not statistically significant in both
areas (P-value >0.05).
The association between BMI, DM, and thyroid dys-
functions with BMD in linear regression model has been
presented in Table 4. In the unadjusted and adjusted
model only the association of BMI with BMD in the
lumbar area (B-unadjusted: 0.013 and B-adjusted: 0.02)
and in the femoral area (B-unadjusted: 0.004 and B-
adjusted: 0.006) were statistically significant.ith BMD in linear regression in lumbar and femoral areas
SE P B adjusted2 SE P-value
0.002 <0.01 0.02 0.002 <0.01
0.03 0.69 0.013 0.03 0.65
0.03 0.26 0.05 0.03 0.11
0.002 0.04 0.006 0.002 <0.01
0.03 0.36 -.023 0.02 0.39
0.03 0.38 0.001 0.02 0.91
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In the present study, in lumbar and femoral areas, the
mean BMI of osteoporotic subjects is lower than normal
and osteopenic subjects and also underweight subject
are more prone to osteoporosis. These findings are con-
sistent with Amiri et al. study which showed that BMI is
associated with osteoporosis and osteopenia [22].
In the present study, no association was found between
DM and BMD, which is consistent with Pajouhi et al. [23].
In contrast, Albright & Reifenstein study [24] and Mima
et al. [25] showed that DM is associated with osteoporosis.
The Moghimi et al. study showed that diabetic women
had lower T-Score and were more prone to osteoporotic
in comparison with healthy women [26]. Also Roe et al
showed that vertebral bone density in insulin-dependent
diabetic children is lower than that in healthy children
[27]. Several studies in children and adults population sup-
port this finding [28,29]. In contrast, other studies showed
that BMD in type II DM subjects is higher or equal to nor-
mal population [30-32]. In another study carried out in
Greece, it was shown that both types of DM exacerbate
osteoporosis [33].
The results of BMD in type I and II DM subjects is differ-
ent or even contradictory [8-11]; so that in some studies
there was no difference between BMD in subjects with type
II DM and healthy subjects, while in a number of other
studies, lower BMD and still in others higher BMD has
been observed [8,10]. The latter was more often observed
in women, which has been attributed to obesity and the in-
creased androgeneity due to hyper Insulin- dependency [7].
The findings of our study regarding the independence of
thyroid dysfunctions from BMD are in contrast with find-
ings reported by Folis [20]. He showed that hyperthyroid-
ism causes bone erosion, declaring that this change in the
bone metabolism is accompanied by degradation of colla-
gen tissue and reduction of the bony density. The role of
thyroid hormones in bone metabolism is not clarified, but
the suggested mechanism involves the impact of T3 on the
osteoclasts causing bone erosion [20]. Likewise, other stud-
ies showed that thyroid dysfunctions would increase the
risk of osteoporosis [33,34]. The low number of subjects
with DM and thyroid dysfunctions in our study population
is the main limitation of this study. The cross sectional
design is another limitation of this study.Conclusion
The results of current study show that underweight sub-
jects are more prone to osteoporosis, but no association
was found between DM and thyroid dysfunctions with
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